Taisho sees Mexican OTC acquisitions as N American springboard
This article was originally published in Scrip
Executive Summary
Helped by the strong yen, the year to date has seen a record value of overseas acquisitions by Japanese firms across all sectors, and Taisho Pharmaceutical is doing its bit to raise the total even further.